Related Experiment Video
Updated: Jun 27, 2026
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
Published on: March 5, 2022
Co-Expression Network and Machine Learning Analysis of Transcriptomics Data Identifies Distinct Gene Signatures and
Eskezeia Y Dessie1, Lili Ding2, Latha Satish1
1Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USA.
Background:
Atopic dermatitis (AD) is a common inflammatory skin condition with complex origins. Current treatments often yield suboptimal results due to an incomplete understanding of its underlying mechanisms. This study aimed to identify pathway and gene signatures that distinguish between lesional AD, non-lesional AD, and healthy skin.
Method:
We conducted differential gene expression and co-expression network analyses to identify differentially co-expressed genes (DCEGs) in lesional AD vs. healthy skin, lesional vs. non-lesional AD, and non-lesional AD vs. healthy skin. Modules associated with lesional and non-lesional AD were identified based on the correlation coefficients between module eigengenes and clinical phenotypes (|R| ≥ 0.5, p-value < 0.05). Subsequently, we employed Ingenuity Pathway Analysis (IPA) on the identified DCEGs, followed by machine learning (ML) analysis within the pathway expression framework. The ML analysis of pathway expressions, selected by IPA and derived from gene expression data, identified relevant pathway signatures, which were validated using an independent dataset and correlated with AD severity measures (EASI and SCORAD).
Results:
We identified 975, 441, and 40 DCEGs in lesional vs. healthy skin, lesional vs. non-lesional, and non-lesional vs. healthy skin, respectively. IPA and ML analyses revealed 25 relevant pathway signatures, including wound healing, glucocorticoid receptor signaling, and S100 gene family signaling pathways. Validation confirmed the significance of 10 pathway signatures, which were correlated with the AD severity measures. DCEGs such as MMP12 and S100A8 demonstrated high diagnostic efficacy (AUC > 0.70) in both the discovery and validation datasets.
Conclusions:
Differential gene expression, co-expression networks and ML analyses of pathway expression have unveiled relevant pathways and gene signatures that distinguish between lesional, non-lesional, and healthy skin, providing valuable insights into AD pathogenesis.
Insights
This study identified key gene and pathway signatures distinguishing atopic dermatitis (AD) skin from healthy skin. These findings offer new insights into AD pathogenesis and potential therapeutic targets.
Area of Science:
- Dermatology
- Genomics
- Bioinformatics
Background:
- Atopic dermatitis (AD) is a prevalent inflammatory skin condition with complex, incompletely understood mechanisms.
- Current AD treatments are often suboptimal due to limited knowledge of disease pathogenesis.
- Identifying distinct molecular signatures in AD skin is crucial for developing targeted therapies.
Purpose of the Study:
- To identify pathway and gene expression signatures differentiating lesional AD, non-lesional AD, and healthy skin.
- To uncover molecular mechanisms underlying AD pathogenesis.
- To validate identified signatures and correlate them with clinical severity.
Main Methods:
- Differential gene expression and co-expression network analyses were performed.
- Ingenuity Pathway Analysis (IPA) and machine learning (ML) were applied to gene expression data.
- Pathway signatures were validated on an independent dataset and correlated with EASI and SCORAD scores.
Main Results:
- Over 900 differentially co-expressed genes (DCEGs) were identified between lesional AD and healthy skin.
- Twenty-five relevant pathway signatures were revealed, including wound healing and glucocorticoid receptor signaling.
- Ten pathway signatures correlated with AD severity, and specific DCEGs (MMP12, S100A8) showed high diagnostic value.
Conclusions:
- Combined analyses of gene expression, co-expression networks, and pathway analysis provide novel insights into AD.
- Distinct molecular signatures differentiate lesional, non-lesional AD, and healthy skin.
- Identified pathways and genes offer potential targets for improved AD diagnosis and treatment.
More Related Videos
07:28JUMPn: A Streamlined Application for Protein Co-Expression Clustering and Network Analysis in Proteomics
Published on: October 19, 2021
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:27Principles of Pharmacogenetics: Types of Genetic Variants